{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":114,"n_cols":5,"rows_kept":114,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[51,2,51,3],[52,2,52,3],[56,2,56,3],[58,2,58,3],[58,4,58,5],[59,2,59,3],[59,4,59,5],[60,2,60,3],[60,4,60,5],[61,2,61,3],[62,2,62,3],[71,2,71,3],[72,2,72,3],[73,2,73,3],[74,2,74,3],[106,2,106,3],[107,2,107,3],[111,2,111,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910788413103321"]
[null,null,"Autore",null,"De Nicolo Gianni"]
[null,null,"Titolo",null,"Bank Risk-Taking and Competition Revisited : : New Theory and New Evidence / / Gianni De Nicolo, Abu M. Jalal, John Boyd"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C. : , : International Monetary Fund, , 2006"]
[null,null,"ISBN",null,"1-4623-4777-0"]
[{"$nulls":4},"1-4527-7939-2"]
[{"$nulls":4},"1-283-45039-9"]
[{"$nulls":4},"9786613823663"]
[{"$nulls":4},"1-4519-1010-X"]
[null,null,"Descrizione fisica",null,"1 online resource (51 p.)"]
[null,null,"Collana",null,"IMF Working Papers"]
[null,null,"Soggetti",null,"Bank failures - Econometric models"]
[{"$nulls":4},"Competition - Econometric models"]
[{"$nulls":4},"Bank loans - Econometric models"]
[{"$nulls":4},"Risk - Econometric models"]
[{"$nulls":4},"Banks and Banking"]
[{"$nulls":4},"Finance: General"]
[{"$nulls":4},"Investments: Bonds"]
[{"$nulls":4},"Macroeconomics"]
[{"$nulls":4},"Industries: Financial Services"]
[{"$nulls":4},"Econometrics"]
[{"$nulls":4},"Banks"]
[{"$nulls":4},"Depository Institutions"]
[{"$nulls":4},"Micro Finance Institutions"]
[{"$nulls":4},"Mortgages"]
[{"$nulls":4},"Financing Policy"]
[{"$nulls":4},"Financial Risk and Risk Management"]
[{"$nulls":4},"Capital and Ownership Structure"]
[{"$nulls":4},"Value of Firms"]
[{"$nulls":4},"Goodwill"]
[{"$nulls":4},"Oligopoly and Other Imperfect Markets"]
[{"$nulls":4},"General Financial Markets: General (includes Measurement and Data)"]
[{"$nulls":4},"Personal Income, Wealth, and Their Distributions"]
[{"$nulls":4},"Estimation"]
[{"$nulls":4},"Banking"]
[{"$nulls":4},"Finance"]
[{"$nulls":4},"Investment & securities"]
[{"$nulls":4},"Econometrics & economic statistics"]
[{"$nulls":4},"Loans"]
[{"$nulls":4},"Bonds"]
[{"$nulls":4},"Competition"]
[{"$nulls":4},"Personal income"]
[{"$nulls":4},"Financial institutions"]
[{"$nulls":4},"National accounts"]
[{"$nulls":4},"Financial markets"]
[{"$nulls":4},"Estimation techniques"]
[{"$nulls":4},"Econometric analysis"]
[{"$nulls":4},"Banks and banking"]
[{"$nulls":4},"Income"]
[{"$nulls":4},"Econometric models"]
[{"$nulls":4},"United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"December 2006.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 48-49)."]
[null,null,"Nota di contenuto",null,"\"\"Bank Risk-Taking and Competition Revisited: New Theory and New Evidence\"\"; \"\"Contents\"\"; \"\"I. INTRODUCTION\"\"; \"\"II. THEORY\"\"; \"\"III. EVIDENCE\"\"; \"\"IV. CONCLUSION\"\"; \"\"Appendix I. Pareto Dominant Equilibria\"\"; \"\"References\"\""]
[null,null,null,"Sommario/riassunto","This paper studies two new models in which banks face a non-trivial asset allocation decision. The first model (CVH) predicts a negative relationship between banks' risk of failure and concentration, indicating a trade-off between competition and stability. The second model (BDN) predicts a positive relationship, suggesting no such trade-off exists. Both models can predict a negative relationship between concentration and bank loan-to-asset ratios, and a nonmonotonic relationship between bank concentration and profitability. We explore these predictions empirically using a cross-sectional sample of about 2,500 U.S. banks in 2003 and a panel data set of about 2,600 banks in 134 nonindustrialized countries for 1993-2004. In both these samples, we find that banks' probability of failure is positively and significantly related to concentration, loan-to-asset ratios are negatively and significantly related to concentration, and bank profits are positively and significantly related to concentration. Thus, the risk predictions of the CVH model are rejected, those of the BDN model are not, there is no trade-off between bank competition and stability, and bank competition fosters the willingness of banks to lend."]
[null,"2.","Record Nr.",null,"UNINA9910807232403321"]
[null,null,"Autore",null,"Saad Bashar"]
[null,null,"Titolo",null,"Greco-Arab and Islamic herbal medicine : traditional system, ethics, safety, efficacy, and regulatory issues"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, : Wiley, 2011"]
[null,null,"ISBN",null,"9786613025746"]
[{"$nulls":4},"9781118002261"]
[{"$nulls":4},"1118002261"]
[{"$nulls":4},"9781283025744"]
[{"$nulls":4},"1283025744"]
[{"$nulls":4},"9780470944363"]
[{"$nulls":4},"0470944366"]
[{"$nulls":4},"9780470944356"]
[{"$nulls":4},"0470944358"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (564 p.)"]
[null,null,"Disciplina",null,"610"]
[null,null,"Soggetti",null,"Herbs --Therapeutic use"]
[{"$nulls":4},"Medicinal plants"]
[{"$nulls":4},"Medicine, Arab"]
[{"$nulls":4},"Medicine, Greek and Roman"]
[{"$nulls":4},"Medicine, Arab - Therapeutic use"]
[{"$nulls":4},"Herbs"]
[{"$nulls":4},"Complementary Therapies"]
[{"$nulls":4},"Biological Science Disciplines"]
[{"$nulls":4},"Pharmacognosy"]
[{"$nulls":4},"Evaluation Studies as Topic"]
[{"$nulls":4},"Medicine, Traditional"]
[{"$nulls":4},"History of Medicine"]
[{"$nulls":4},"Humanities"]
[{"$nulls":4},"Biological Products"]
[{"$nulls":4},"Botany"]
[{"$nulls":4},"Complex Mixtures"]
[{"$nulls":4},"Therapeutics"]
[{"$nulls":4},"Investigative Techniques"]
[{"$nulls":4},"Health Occupations"]
[{"$nulls":4},"Natural Science Disciplines"]
[{"$nulls":4},"Culture"]
[{"$nulls":4},"Anthropology, Cultural"]
[{"$nulls":4},"Biology"]
[{"$nulls":4},"Anthropology"]
[{"$nulls":4},"Social Sciences"]
[{"$nulls":4},"Herbal Medicine"]
[{"$nulls":4},"Medicine, Arabic"]
[{"$nulls":4},"Pharmacology"]
[{"$nulls":4},"Plant Preparations"]
[{"$nulls":4},"Drug Evaluation"]
[{"$nulls":4},"History"]
[{"$nulls":4},"Phytotherapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"GRECO-ARAB AND ISLAMIC HERBAL MEDICINE: TRADITIONAL SYSTEM, ETHICS, SAFETY, EFFICACY, AND REGULATORY ISSUES; CONTENTS; FOREWORD; PREFACE; ACKNOWLEDGMENTS; 1 An Overview of Greco-Arab and Islamic Herbal Medicine; 2 History of Greco-Arab and Islamic Medicine; 3 Herbal Medicine; 4 The Arab-Islamic Roots of Western Medicine; 5 Contributions of Arab and Islamic Scholars to Modern Pharmacology; 6 Natural Drugs in Greco-Arabic and Islamic Medicine; 7 Method of Therapy in Greco-Arab and Islamic Medicine; 8 Commonly Used Herbal Medicines in the Mediterranean"]
[{"$nulls":4},"9 The Current State of Knowledge of Arab Herbal Medicine10 Greco-Arab and Islamic Medicine Practiced Outside the Middle East; 11 Biosafety of Herbal Medicine; 12 Arab Medicinal Plants: From Traditional Uses to Scientific Knowledge; 13 Modern In Vitro Test Systems; 14 Modern In Vivo Evaluations and Clinical Trials; 15 Medical Ethics in Arab and Islamic Medicine; 16 Medicinal Herbs and Extracting Their Active Ingredients; 17 Food Therapy; 18 Drug Development from Herbal Sources; 19 Herbal Remedies: Use and Demographic and Regulatory Issues; APPENDIX A: Plant Naming; INDEX; Colour Plates"]
[null,null,null,"Sommario/riassunto","This book presents a systematic review on traditional Arab herbal medicine including historical background, medical innovations introduced by Arab physicians, common roots of Arab medicine and western medicine, methodology of drug discovery and therapy in Arabic and Islamic medicine, a state-of-the-art description of traditional Arab herbal medicine, and evidence-based safety and efficacy of Arab and Islamic medicines. The usage of modern cell biological, biochemical, in vitro and in vivo techniques for the evaluation of medicinal plant safety and efficacy is also discussed. The toxicity of he"]